Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
| MER Indicator |
MER description |
Target Fiscal Year |
Target |
| INVS_COMD |
HIV CD4 Tests: Dollars planned (COP)/ spent (Actual) |
2017 |
100,000 |
| INVS_COMD |
HIV Viral Load: Dollars planned (COP)/ spent (Actual) |
2017 |
500,000 |
| INVS_COMD |
Number of HIV CD4 Reagents purchased |
2017 |
100,000 |
| INVS_COMD |
Number of HIV Viral Load Reagents purchased |
2017 |
500,000 |
| INVS_COMD |
PEPFAR resources used for HIV-program related commodities: planned & purchased in the last 12 months by Implementing Partner |
2017 |
600,000 |
| LAB_PT |
CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
24 |
| LAB_PT |
CD4: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
9 |
| LAB_PT |
CD4: Number of laboratories that participate in this PT program |
2017 |
24 |
| LAB_PT |
CD4: Number of laboratories that participate in this PT program |
2017 |
9 |
| LAB_PT |
CD4: Number of laboratories that perform this testing |
2017 |
24 |
| LAB_PT |
CD4: Number of laboratories that perform this testing |
2017 |
9 |
| LAB_PT |
Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
1 |
| LAB_PT |
Early infant diagnostics: Number of laboratories that participate in this PT program |
2017 |
1 |
| LAB_PT |
Early infant diagnostics: Number of laboratories that perform this testing |
2017 |
1 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
101 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
9 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program |
2017 |
101 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program |
2017 |
9 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that perform this testing |
2017 |
101 |
| LAB_PT |
HIV serologic/diagnostic testing: Number of laboratories that perform this testing |
2017 |
9 |
| LAB_PT |
HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
1 |
| LAB_PT |
HIV viral load: Number of laboratories that participate in this PT program |
2017 |
1 |
| LAB_PT |
HIV viral load: Number of laboratories that perform this testing |
2017 |
1 |
| LAB_PT |
TB diagnostics (AFB microscopy): Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
9 |
| LAB_PT |
TB diagnostics (AFB microscopy): Number of laboratories that participate in this PT program |
2017 |
9 |
| LAB_PT |
TB diagnostics (AFB microscopy): Number of laboratories that perform this testing |
2017 |
9 |
| LAB_PT |
TB diagnostics (Culture/DST): Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
1 |
| LAB_PT |
TB diagnostics (Culture/DST): Number of laboratories that participate in this PT program |
2017 |
1 |
| LAB_PT |
TB diagnostics (Culture/DST): Number of laboratories that perform this testing |
2017 |
1 |
| LAB_PT |
TB diagnostics (Xpert MTB/RIF): Number of laboratories that achieve acceptable successful passing criteria in this PT program |
2017 |
9 |
| LAB_PT |
TB diagnostics (Xpert MTB/RIF): Number of laboratories that participate in this PT program |
2017 |
9 |
| LAB_PT |
TB diagnostics (Xpert MTB/RIF): Number of laboratories that perform this testing |
2017 |
9 |
| PMTCT_EID |
By infants who received a virologic test within 2 months of birth |
2017 |
260 |
| PMTCT_EID |
By infants who received their first virologic HIV test between 2 and 12 months of age |
2017 |
116 |
| PMTCT_EID |
Number of infants with a positive virological test result within 12 months of birth |
2017 |
7 |
| PMTCT_EID |
Number of infants with a positive virological test result within 2 months of birth |
2017 |
7 |
| PMTCT_EID |
Sum of Infant Age disaggregates |
2017 |
376 |
| TX_PVLS |
Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months |
2017 |
35,174 |
| TX_PVLS |
Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months |
2017 |
31,657 |
| TX_PVLS |
Numerator Aggregated Age/Sex: <15 Female |
2017 |
1,248 |
| TX_PVLS |
Numerator Aggregated Age/Sex: <15 Male |
2017 |
913 |
| TX_PVLS |
Numerator Aggregated Age/Sex: 15+ Female |
2017 |
19,293 |
| TX_PVLS |
Numerator Aggregated Age/Sex: 15+ Male |
2017 |
10,206 |
| TX_PVLS |
Numerator: Indication: Routine |
2017 |
31,657 |
| TX_PVLS_den |
Denominator Aggregated Age/Sex: <15 Female |
2017 |
1,342 |
| TX_PVLS_den |
Denominator Aggregated Age/Sex: <15 Male |
2017 |
1,401 |
| TX_PVLS_den |
Denominator Aggregated Age/Sex: 15+ Female |
2017 |
21,053 |
| TX_PVLS_den |
Denominator Aggregated Age/Sex: 15+ Male |
2017 |
11,126 |
| TX_PVLS_den |
Denominator: Indication: Routine |
2017 |
35,174 |
